Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rhythm Biosciences Ltd. ( (AU:RHY) ) just unveiled an update.
Rhythm Biosciences Ltd. has announced the application for quotation of 483,871 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective June 2, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting its operations and stakeholder interests positively.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of diagnostic technologies. The company is primarily engaged in creating products that aid in the early detection of diseases, with a market focus on enhancing healthcare outcomes through innovative solutions.
Average Trading Volume: 231,399
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$18.84M
Learn more about RHY stock on TipRanks’ Stock Analysis page.